Jazz Pharmaceuticals Stock Forecast

Stock Price Forecast

The 13 analysts that cover Jazz Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $215.92, which forecasts a 18.47% increase in the stock price over the next year. The lowest target is $172 and the highest is $275.

Price Target: $215.92 (+18.47%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$172	$215.92	$219	$275
Change	-5.63%	+18.47%	+20.16%	+50.88%

Analyst Ratings

The average analyst rating for Jazz Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	6	6	6	6	6	4
Buy	8	8	8	8	9	8
Hold	1	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	16	16	16	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Etzer Darout Barclays	Barclays	Buy Initiates $224	Buy	Initiates	$224	+22.90%	Feb 27, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $191 → $195	Buy	Maintains	$191 → $195	+6.99%	Feb 25, 2026
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $225 → $226	Buy	Maintains	$225 → $226	+24.00%	Feb 25, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $235 → $250	Buy	Maintains	$235 → $250	+37.17%	Feb 25, 2026
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $263 → $275	Strong Buy	Maintains	$263 → $275	+50.88%	Feb 25, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.53B

from 4.27B

6.17%

from 4.27B

Revenue Next Year

4.88B

from 4.53B

7.66%

from 4.53B

EPS This Year

24.93

from -5.84

EPS Next Year

25.26

from 24.93

1.34%

from 24.93

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.09B	3.66B	3.83B	4.07B	4.27B	4.53B	4.88B
Revenue Growth	30.91%	18.26%	4.78%	6.12%	4.88%	6.17%	7.66%
EPS	-5.52	-3.58	6.10	8.65	-5.84	24.93	25.26
EPS Growth	-	-	-	41.75%	-	-	1.34%
Forward PE	-	-	-	-	-	7.31	7.21
No. Analysts	-	-	-	-	-	20	20

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	4.7B	5.4B
Avg	4.5B	4.9B
Low	4.3B	4.4B

Revenue Growth

Revenue Growth	2026	2027
High	11.1%	18.3%
Avg	6.2%	7.7%
Low	0.5%	-2.1%

EPS Forecast

EPS	2026	2027
High	38.47	32.59
Avg	24.93	25.26
Low	21.45	21.30

EPS Growth

EPS Growth	2026	2027
High	-	30.7%
Avg	-	1.3%
Low	-	-14.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.